Novel biodegradable biopolymer-Bioglass-composite implant technology - BioIMplant

Project summary

In the treatment of bone-related diseases and fractures, surgical removal of osteosyntheses following bone healing is frequently required, resulting in further trauma, expense, and waste. BioImplant aims to eliminate such surgeries, while also aiding in the healing process of affected bones, by using novel composites that are metabolised and serve as slow-release sources of beneficial compounds for the production of osteosyntheses. The consortium of leading experts in polymer composites, compatibilisation and bioceramics, seeks to develop (TRL 2 to TRL 4) process-specific biopolymer/Bioglass composites with bifunctional compatabilisers/growth factors. Such development is crucial in light of Europe and Asia's ageing populations, necessitating heightened medical intervention. BioImplant seeks to address this need and thereby achieve significant social, scientific and commercial impacts. In doing so, valuable scientific insight and intellectual property will be developed and implemented.